SUPARTZ® (Italian)

SUPARTZ is an FDA-approved, non-opioid therapy designed to alleviate knee pain associated with osteoarthritis (OA). This treatment utilizes highly purified, animal-derived hyaluronic acid, a substance naturally present in joint fluid that acts as a lubricant and shock absorber.

SUPARTZ Indications

Medical professionals may recommend SUPARTZ products or injections for individuals who have not responded to the first-line therapies for knee osteoarthritis. It’s important to note that SUPARTZ FX is not suitable for everyone; individuals with knee joint infections, skin diseases at the injection site, allergies to poultry products, or those who are pregnant or breastfeeding should consult their healthcare provider before starting treatment.

SUPARTZ FX aims to reduce pain and improve joint function in patients who have not responded adequately to conservative treatments such as physical therapy or simple analgesics.

How to administer SUPARTZ FX?

Medical professionals must administer SUPARTZ injections directly into the affected knee joint through a series of intra-articular injections. Clinical studies have demonstrated that some individuals experience symptom relief after just three injections, with SUPARTZ treatment benefits lasting up to six months.

SUPARTZ is a sterile, non-pyrogenic injectable solution primarily composed of sodium hyaluronate, a derivative of hyaluronic acid known for its exceptional water-retaining properties.

SUPARTZ Injection Ingredients

Each 1 mL of SUPARTZ contains 10 mg of sodium hyaluronate dissolved in physiological saline, resulting in a 1.0% solution.

In addition to sodium hyaluronate, the formulation includes sodium chloride (21.25 mg), dibasic sodium phosphate dodecahydrate (1.343 mg), sodium dihydrogen phosphate dihydrate (0.04 mg), and water for injection. These ingredients work together to enhance joint lubrication, reduce pain, and improve mobility in individuals with knee osteoarthritis.

SUPARTZ is a viscosupplement composed of purified hyaluronan (10 mg/mL), designed to replenish synovial fluid in knee joints, enhancing mobility and reducing pain.

How to Store SUPARTZ Injections

To ensure the effectiveness of SUPARTZ injections, proper storage is essential. SUPARTZ should be stored in its original packaging at controlled room temperatures, ideally between 2°C and 25°C (36°F to 77°F), and must not be frozen.

It is crucial to keep the syringes protected from direct light and excessive heat. The product should be stored in a clean, dry environment and used only before the expiration date indicated on the packaging. It should not be used if the packaging is damaged or the product has been frozen. Always check the product for any signs of contamination or damage before administering. Following these storage guidelines ensures the quality and safety of the treatment for patients.

Packaging Inclusions of SUPARTZ Knee Injection

SUPARTZ knee injections are formulated to relieve knee osteoarthritis symptoms, such as pain and inflammation, through intra-articular administration. When you order SUPARTZ online at Maylips, each packaging box only contains 5×2.5mL pre-filled syringes and the package insert.

Ordering SUPARTZ knee injections through Maylips.com is straightforward and aims to provide adequate relief for knee osteoarthritis sufferers. To place an order, visit Maylips.com, navigate the SUPARTZ product page, and select the desired quantity.

Ordering SUPARTZ Knee Product

After adding the product to your cart, proceed to checkout, providing necessary shipping and payment details to buy SUPARTZ. The supplier also provides efficient order tracking of your SUPARTZ injection purchases. Maylips.com offers free shipping for specific amounts, competitive wholesale prices, and accepts various payment methods, including major credit cards.

SUPARTZ Manufacturer – Seikagaku Corp.

SUPARTZ injection is manufactured by Seikagaku Corporation, a leading global biotechnology company based in Japan. Specializing in developing and producing biopharmaceuticals, Seikagaku is renowned for its innovative contributions to joint care treatments, particularly in the field of viscosupplementation. SUPARTZ, their flagship product, is a hyaluronic acid-based injection designed to alleviate pain and improve mobility for individuals suffering from knee osteoarthritis.

With decades of expertise in the research and development of hyaluronic acid-based therapies, Seikagaku ensures that SUPARTZ is produced to the highest quality, safety, and efficacy standards. The company is committed to advancing the treatment of musculoskeletal conditions and improving the quality of life for patients worldwide.

Warning! The product is intended solely for professional use in a medical environment and under professional supervision. The product is supplied to medical professionals who specialize in aesthetic medicine (plastic surgery, facial treatments) and work under individual medical licenses as aestheticians or in dedicated clinics. Unprofessional use by individuals without a medical background may lead to severe adverse effects and health harm.